Details for New Drug Application (NDA): 211505
✉ Email this page to a colleague
The generic ingredient in DIVALPROEX SODIUM is divalproex sodium. There are eighteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.
Summary for 211505
Tradename: | DIVALPROEX SODIUM |
Applicant: | Teva Pharms Usa |
Ingredient: | divalproex sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | EQ 125MG VALPROIC ACID | ||||
Approval Date: | Nov 17, 2020 | TE: | RLD: | No |
Complete Access Available with Subscription